The Big Five South Korean general hospitals have registered a novel antifungal drug Cresemba for prescription.

Pharmaceutical industry sources reported the Drug Committee (DC) at all of the Big Five general hospitals in South Korea, including Samsung Medical Center, Seoul National University Hospital, Seoul St. Mary's Hospital and Severance Hospital, have recently passed Cresemba (isavuconazonium).

However, the drug faces an issue with the healthcare reimbursement. In last year, the Health Insurance Review and Assessment Service (HIRA) internally revised the regulation on the pharmaceutical reimbursement subject evaluation standard and procedure. HIRA narrowed the scope of prospective s